文献速递胸部肿瘤放疗放疗物理与技术

系列4DCT/4DPET成像预测和监测局部晚期非小细胞肺癌化放疗反应

Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy.
PubMed 文献 · Radiother Oncol · 2017-12-12

限制分析至p<0.005时,多个体积特征及其变化率与2年结局显著相关,且涉及淋巴结病变的影像特征是唯一与总生存相关的特征。

要点

  • 4DPET/4DCT的多个体积特征及其变化率可在多个时间点与结局显著相关(p<0.005)。
  • 涉及淋巴结病变的影像特征是唯一与总生存相关的特征。
  • 自适应化放疗的最佳时间并非唯一受限于成像时间点。

核心结论

  • 多个4DPET/CT特征及其变化率可在多个时间点与结局(包括总生存)达到显著关联(p<0.005)。
  • 自适应化放疗的最佳时间因此并非唯一受限于成像时间点。

研究设计与样本

  • 连续入组接受根治性化放疗的局部晚期非小细胞肺癌患者。
  • 在IMRT治疗第0、2、4、7周采集4DPET/4DCT扫描。
  • 共招募32例连续患者,27例完成所有扫描。

主要发现

  • 限制分析至4DPET/4DCT特征及变化率且p<0.005时,多个体积特征及其变化率达到显著。
  • 涉及淋巴结病变的影像特征是唯一与总生存相关的特征。

关键数值与推荐

  • 分析限定p<0.005的4DPET/4DCT特征及变化率。
  • 结局评估时间为化放疗后2年。

临床怎么用

  • 系列4DPET/4DCT成像特征及其变化率可用于预测和监测局部晚期非小细胞肺癌化放疗反应。
  • 涉及淋巴结病变的影像特征对总生存具有独特预后价值。

局限性

  • 共招募32例连续患者,27例完成所有扫描。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: A FDG-PET/CT image feature with optimal prognostic potential for locally-advanced non-small cell lung cancer (LA-NSCLC) patients has yet to be identified, and neither has the optimal time for FDG-PET/CT response assessment; furthermore, nodal features have been largely ignored in the literature. We propose to identify image features or imaging time point with maximal prognostic power. MATERIALS AND METHODS: Consecutive consenting patients with LA-NSCLC receiving curative intent CRT were enrolled. 4DPET/4DCT scans were acquired 0, 2, 4, and 7 weeks during IMRT treatment. Eleven image features and their rates of change were recorded for each time point and tested for each of the possible outcome 2 years post CRT using the Kaplan-Meier method. RESULTS: 32 consecutive patients were recruited, 27 completing all scans. Restricting analysis to 4DPET/4DCT features and rates of change with p < 0.005, several volume-based features and their rates of change reached significance. Image features involving nodal disease were the only ones associated with overall survival. CONCLUSIONS: Several 4DPET/CT features and rates of change can reach significant association (p < 0.005) with outcomes, including overall survival, at many time points. The optimal time for adaptive CRT is therefore not constrained uniquely on imaging.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Bissonnette JP, Yap ML, Clarke K, et al. Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy. Radiother Oncol. 2017. PMID: 29246584. doi:10.1016/j.radonc.2017.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。